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Abstract
Background: Nociception requires transduction and impulse electrogenesis in nerve fibers which innervate the
body surface, including the skin. However, the molecular substrates for transduction and action potential initiation in
nociceptors are incompletely understood. In this study, we examined the expression and distribution of Na
+/Ca
2+
exchanger (NCX) and voltage-gated sodium channel isoforms in intra-epidermal free nerve terminals.
Results: Small diameter DRG neurons exhibited robust NCX2, but not NCX1 or NCX3 immunolabeling, and virtually
all PGP 9.5-positive intra-epidermal free nerve terminals displayed NCX2 immunoreactivity. Sodium channel NaV1.1
was not detectable in free nerve endings. In contrast, the majority of nerve terminals displayed detectable levels of
expression of NaV1.6, NaV1.7, NaV1.8 and NaV1.9. Sodium channel immunoreactivity in the free nerve endings
extended from the dermal boundary to the terminal tip. A similar pattern of NCX and sodium channel
immunolabeling was observed in DRG neurons in vitro.
Conclusions: NCX2, as well as NaV1.6, NaV1.7, NaV1.8 and NaV1.9, are present in most intra-epidermal free nerve
endings. The presence of NCX2, together with multiple sodium channel isoforms, in free nerve endings may have
important functional implications.
Background
Nociception begins with transduction and action potential
electrogenesis in nerve fibers, many of which terminate
close to the body surface in the skin epidermis. However,
our knowledge of the molecular makeup of peripheral epi-
dermal nerve terminals, which include nociceptors,
remains incomplete. Distinct populations of free nerve
terminals express CGRP or Mrgprd and have been shown
to have P2Y2, P2X3 and TRPV1 receptors which are
known to contribute to transduction by free nerve endings
[1-4]. However, while it is now well-recognized that dorsal
root ganglion (DRG) neurons, including nociceptors,
express multiple sodium channel isoforms which contri-
bute to electrogenesis within these cells [5,6], the regional
distribution of these channel isoforms within nociceptor
cell bodies, axons, and free nerve terminals is less well
understood, in part as a result of the small (< 0.5 μm)
diameters of the epidermal nerve endings. Most functional
studies on sodium channel expression of DRG neurons
have focused on the cell bodies which are amenable to
patch clamp recording. In contrast, only a few electrophy-
siological studies have examined the contribution of
sodium channels to the function of sensory terminals
[7-10]. Although these studies provide evidence for
the presence of tetrodotoxin (TTX)-sensitive and TTX-
resistant sodium channel subtypes in nociceptive nerve
terminals, most of these studies examined corneal [7,8]
and epidural [9] nerve endings and only one study [10]
focused on axons innervating the skin, and these studies
do not provide a comprehensive demonstration of the pat-
tern of expression of the sodium channel isoforms within
the distal terminal endings of nociceptive afferents.
The Na
+/Ca
2+ exchanger (NCX) normally operates as an
antiporter that extrudes Ca
2+ from the cell. Three distinct
isoforms of NCX (NCX1-3) have been cloned [11-13], and
all are expressed in the CNS [14]. NCX has been linked to
functions that include vesicle recycling and pre-synaptic
excitability in the terminals of cultured neurons [15].
In the PNS, NCX is known to be expressed [16] and
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trunks, and has been shown to be present within cell
bodies of DRG neurons, where it appears to play a role in
Ca
2+ homeostasis [18]. However, it is not known whether
NCX is present along non-myelinated axons, and expres-
sion of NCX in intra-epidermal free nerve terminals has
not been studied.
In this paper, we demonstrate the presence of the
NCX2 isoform of the Na
+/Ca
2+ exchanger within free
nerve endings within the epidermis. In addition, we
demonstrate the expression of sodium channels NaV1.6,
NaV1.7, NaV1.8 and NaV1.9 within axons composing
small nerve bundles subjacent to epidermis and in the
epidermal free nerve terminals. NCX2 and these sodium
channel isoforms are present within the free nerve end-
ings from the dermal boundary to the tips of the slender
intra-epidermal endings. The presence of NCX2, together
with sodium channel isoforms NaV1.6, NaV1.7, NaV1.8,
and NaV1.9, may have important implications for the
function and pathophysiology of small-diameter sensory
nerve endings.
Results
In this study, we investigated the expression and distribu-
tion of Na
+/Ca
2+ exchanger (NCX) and voltage-dependent
Na
+ channel isoforms in axons and free nerve terminals
within skin dermis and epidermis. To establish the identity
of NCX isoforms that are expressed by small diameter
(< 25 μm) dorsal root ganglia (DRG) neurons, which give
rise to C- and Aδ-fibers that terminate as free nerve end-
ings in the skin, we reacted sections of DRG with antibo-
dies specific to NCX isoforms. As shown in Figure 1 DRG
neurons of all size classes exhibited minimal NCX1 immu-
nolabeling. However, satellite cells ensheathing DRG neu-
rons displayed robust NCX1 reactivity. In contrast to the
limited NCX1 labeling in all DRG neurons, NCX2 immu-
nolabeling was prominent in small diameter DRG neurons
and was generally not above background levels in larger
diameter neurons (Figure 1). Virtually all small diameter
DRG neurons exhibited NCX2 immunolabeling. DRG
neurons of all size classes displayed a low level of NCX3
labeling.
Free nerve terminals in the epidermis, in most cases
with diameters of less that 0.5 μm, were identified by label-
ing with an antibody to PGP 9.5. In epidermis, NCX1 was
not detectable in free nerve endings (Figure 2). In contrast,
PGP 9.5-positive free nerve terminals displayed robust
immunolabeling for NCX2, consistent with expression of
NCX2 in the cell bodies of small diameter DRG neurons.
NCX3 immunolabeling was not detectable in free nerve
endings in epidermis, although we were able to discrimi-
nate low levels of NCX3 reactivity in small diameter DRG
neurons. In sections of epidermis that displayed multiple
free nerve terminals (Figure 3), NCX2 immunolabeling
was exhibited by all PGP9.5-positive nerve endings. We
assessed the labeling of 50 PGP 9.5-positive free nerve
endings within skin samples and detected NCX2 labeling
in all nerve endings. Prominent NCX2 immunoreactivity
was also displayed by the small nerve bundles of axons
within the dermis immediately subjacent to the epidermis
(Figure 3).
We also examined cultured DRG neurons to deter-
mine whether the DRG neuronal cell bodies and pro-
cesses in vitro displayed a similar pattern of NCX
labeling as observed in vivo. Consistent with the labeling
pattern observed in vivo, NCX1 immunolabeling was
not detectable and only extremely low levels of NCX3
reactivity were exhibited in cultured neuronal cell bodies
and neurites (data not shown). In contrast, cultured
DRG neurons exhibited robust NCX2 immunoreactivity
within cell bodies and neurites (Figure 4A). The NCX2
labeling of neurites extended throughout their entire
length, and was clearly present at the neuritic tips
(Figure 4B).
To examine the expression of sodium channels within
axons and free nerve terminals of skin dermis and epi-
dermis, we reacted sections of skin tissue with antibo-
dies specific for sodium channel isoforms that are
expressed within DRG neurons (i.e. NaV1.1, NaV1.6,
NaV1.7, NaV1.8 and NaV1.9; [19]). In the small nerve
bundles of PGP 9.5-positive fibers within dermis imme-
diately subjacent to epidermis, NaV1.1 labeling was not
detectable (Figure 5), consistent with limited NaV1.1
expression that has been reported within small DRG
neurons [20]. In contrast, robust labeling for NaV1.6,
NaV1.7, NaV1.8 and NaV1.9 was exhibited in the PGP
9.5-positive axons in the small nerve bundles within the
dermis. The labeling for these sodium channels was gen-
erally evenly distributed along the axons and was not
patchy or aggregated in specific regions of the PGP 9.5-
positive fibers.
Axons that exit the nerve bundles become fine caliber
(~0.2 - 0.5 μm diam.) free nerve endings upon passing
through the basement membrane separating dermis from
epidermis; these nerve terminals extend towards the skin
surface with a tortuous, non-linear trajectory and often
exhibit varicosities of variable sizes along their lengths,
further complicating analysis. Nonetheless, in favorable
sections we observed a pattern of sodium channel immu-
nolabeling that paralleled that in DRG neuronal cell
bodies. As anticipated, NaV1.1 immunolabeling was not
detectable in the PGP 9.5-positive free nerve endings
(Figure 6). However, NaV1.6, NaV1.7, NaV1.8 and NaV1.9
immunolabeling was clearly displayed by PGP 9.5-
positive free nerve terminals. While difficult to assess due
to the small diameter and tortuous course exhibited by
free nerve terminals in epidermis, the sodium channel
immunoreactivity appeared to extend to the tips of the
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of the nerve terminals to the distal tips. The varicosities
of the free nerve endings exhibited clear labeling for
these channels, with generally less intense staining in the
regions between the varicosities. The percentage of PGP
9.5-positive nerve terminals that exhibited NaV1.6,
NaV1.7, NaV1.8 and NaV1.9 immunolabeling in skin was
assessed in the most heavily stained sections (n = 50
nerve endings per sodium channel isoform). NaV1.6,
NaV1.7, NaV1.8 and NaV1.9 immunolabeling was detect-
able in 70%, 90%, 96% and 93%, respectively, of PGP 9.5-
positive nerve terminals.
Since NaV1.7 and NaV1.8 are physiologically coupled
and the presence or absence of co-expression of NaV1.7
and NaV1.8 can markedly alter the excitability of
neurons [21], we also used double label immunostaining
to directly examine whether these sodium channel iso-
forms are co-expressed in free nerve terminals. As
shown in Figure 7 NaV1.7 and NaV1.8 were co-localized
in axons within small nerve bundles adjacent to the epi-
dermis and free nerve endings within the epidermis.
NaV1.7 and NaV1.8 were both present and were co-
localized within the varicosities and inter-connecting
regions of the nerve terminals.
As with the distribution of NCX isoforms in cultured
DRG neurons, we determined whether sodium channels
NaV1.1, NaV1.6, NaV1.7, NaV1.8 and NaV1.9 are targeted
to neurites and are translocated to neuritic tips in DRG
neurons in vitro. For this examination, the distribution
of NaV1.1, NaV1.8 and NaV1.9 in neurites was assessed
Figure 1 Na
+/Ca
2+ exchanger isoforms in rat dorsal root ganglion. NCX1 is not detectable in DRG neurons (PGP 9.5 positive), but exhibits
robust expression in the ensheathing satellite cells. NCX2 is highly expressed in DRG neurons with small diameters. Low levels of NCX3 are
present in most neurons irrespective of cell body diameter. NCX1, 2, and 3: red; PGP 9.5: green; merge: yellow. Scale bar, 50 μm.
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NaV1.6 and NaV1.7, we also employed transfection of
DRG neurons with NaV1.6-EGFP and NaV1.7-EGFP
constructs, supplemented with anti-GFP antibody detec-
tion. While NaV1.1 is expressed within cell bodies of
some DRG neurons in vitro,N a V1.1 immunolabeling
was detected only in the most proximal peripherin-posi-
tive neurites and was not apparent at the neuritic tips
(Figure 8). In contrast, NaV1.6, NaV1.7, NaV1.8 and
NaV1.9 sodium channels are distributed along the
lengths of peripherin-positive neurites, which often dis-
played multiple branching and extensive lengths. Impor-
tantly, the distribution of the sodium channels extended
to the neuritic endings (Figure 8 rightmost panels), with
many neurite tips exhibiting extensive aggregation of the
channels. Non-transfected cultures of DRG neurons,
immunolabeled with isoforms-specific NaV1.6 and
NaV1.7 antibodies, displayed similar patterns of sodium
channel expression along the neurites as the transfected
neurons (Figure 8 insets).
Figure 2 N C Xe x p r e s s i o ni nf r e en e r v ee n d i n g sw i t h i ne p i d e r m i s . PGP 9.5-positive free nerve endings exhibit NCX2, but not NCX1 and
NCX3 immunolabelling. NCX2 labeling extends from the dermal boundary to the tip of the nerve terminal. NCX: red; PGP 9.5: green; merge:
yellow. Scale bar, 10 μm.
Figure 3 NCX2 expression in dermal nerve bundles and epidermal nerve endings. Small bundles of axons in the dermis subjacent to the
epidermis exhibit NCX2 immunolabeling. Virtually all PGP 9.5-positive free nerve endings in the epidermis display NCX2 immunoreactivity.
Dashed line indicates the border between epidermis (top) and dermis (bottom). NCX2: red; PGP 9.5: green; merge: yellow. Scale bar, 20 μm.
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In this study, we have demonstrated the presence of the
NCX2 isoform of the Na
+/Ca
2+ exchanger (NCX),
together with sodium channel isoforms NaV1.6, NaV1.7,
NaV1.8, and NaV1.9 within intra-epidermal free nerve
terminals which include nociceptive endings. Our results
are novel in demonstrating the presence of NCX2 in vir-
tually all of the small-diameter axons and their terminals
in the epidermis, and show that NaV1.6, NaV1.7, NaV1.8,
and NaV1.9 are detectable in a majority of epidermal
Figure 4 NCX2 expression in DRG neurons in vitro. A. NCX2 (green) immunoreactivity in the cell body and neurites of a peripherin-positive
(red) neuron. Merged image (yellow) demonstrates co-localization of NCX2 and peripherin. B. High magnification image showing NCX2 (yellow
= merge of NCX2 and PGP 9.5 signals) present at a neurite tip (indicated with arrow, left image). Scale bars, 50 μm (left); 10 μm (right).
Figure 5 Sodium channel expression in nerve bundles within the dermis. The small bundles of fibers within the dermis subjacent to the
epidermis exhibit NaV1.6, NaV1.7, NaV1.8 and NaV1.9 immunolabeling. NaV1.1 immunolabeling is not detectable within the small nerve bundles.
Sodium channels: red; PGP 9.5: green; merge: yellow. Scale bar, 10 μm.
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NaV1.7, NaV1,8 and NaV1.9 immunolabeling (red). NaV1.1 is not detectable in epidermal nerve fibers. Scale bar, 10 μm.
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in these terminals, Verdru et al. [18] reported sodium-
calcium exchange, and expression of mRNAs for multi-
ple NCX isoforms including NCX2, in rat DRG neurons,
and our studies demonstrate NCX2 within DRG neuro-
nal cell bodies. Our observations in epidermal nerve
endings extend earlier observations by Toledo-Aral et al.
[22] who observed NaV1.7 within the growth cones of
DRG neurons in culture, Black et al. [23] who observed
NaV1.6 in axons within the skin, and Zhao et al. [24]
who described NaV1.8 and NaV1.9 in nerve endings in
epidermis. Notably, our results demonstrate that NCX2
is present within virtually all epidermal nerve terminals
and thus indicate that NCX is present in terminals that
express NaV1.6, NaV1.7, NaV1.8 and NaV1.9. Our results
also demonstrate the co-localization of NaV1.7 and
NaV1.8 within intra-epidermal nerve fibers, a result that
is functionally important since NaV1.7 and NaV1.8 play
different and interdependent roles in electrogenesis
[6,21].
Electrophysiological recordings indicate that a tetrodo-
toxin (TTX)-resistant sodium channel isoform, presum-
ably NaV1.8 on the basis of kinetics, is expressed at
levels that can support action potential electrogenesis,
together with unspecified TTX-sensitive sodium chan-
nels that contribute to excitability, within terminal
branches of C- and Aδ-type dural afferent axons [9].
Similarly, TTX-resistant sodium channels have been
shown to support action potentials within polymodal,
mechanosensory, and cold-sensitive nerve terminals in
the cornea, where action potential electrogenesis is also
partially supported by TTX-sensitive sodium channels
[7]. There is also evidence indicating that TTX-resistant
sodium channels (probably NaV1.8) allow the superficial
endings of slowly conducting nociceptive fibers to con-
duct impulses at low temperatures [10]. A role of
sodium channels in transduction in sensory axon term-
inals is also suggested by the observation that 6.0 μM
TTX attenuates receptor potentials in Pacinian corpus-
cles [25], although this concentration does not differ-
entiate between TTX-sensitive and TTX-resistant
channels and thus provides no information about the
molecular identity of the channels. There is also electro-
physiological evidence indicating that, along C-fiber
trunks, NaV1.6 [23] and sodium channels with physiolo-
gical properties suggestive of NaV1.7 and NaV1.8 [26]
contribute to action potential propagation.
It is possible that some intra-epidermal nerve fibers
may express low densities of channels that are below
the threshold for detection by immunocytochemical
methods, so the percentages of fibers expressing sodium
channel isoforms that we report may represent
Figure 7 Co-localization of NaV1.8 and NaV1.7 in epidermal nerve endings.N a V1.8 (red) and NaV1.7 (green) are co-localized (yellow) in
dermal nerve bundles subadjacent to the epidermis and in single intra-epidermal nerve terminals. Scale bar, 5 μm.
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Page 7 of 13Figure 8 Sodium channel expression in DRG neurons in vitro. Left panels: NaV1.6-EGFP, NaV1.7-EGFP, NaV1,8 and NaV1.9 immunolabeling is
displayed within DRG cell bodies and neurites. NaV1.1 is detectable at low levels in the cell body and only in neurites close to the cell body.
Right panel: High magnification of neurite endings: tips of free nerve terminals exhibit NaV1.6-EGFP, NaV1.7-EGFP, NaV1.8 and NaV1.9
immunolabeling. NaV1.1 immunostaining is not detectable in neuritic nerve ending. Sodium channels: green; PGP 9.5: red; merge: yellow. Insets:
Peripherin-positive (green) neurite tips exhibit immunolabeling (red) with antibodies directed against NaV1.6 and NaV1.7. Scale bar, 50 μm (left),
10 μm (right).
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information about the density of functional sodium
channels within the membrane of the epidermal nerve
endings. Low sodium channel densities (as low as 1-3/
μm
2) can support action potential electrogenesis in neu-
ronal compartments such as small-diameter axons with
high input impedances [27,28]. There may in fact be
functional benefit to limiting sodium channel density
w i t h i ns e n s o r yt e r m i n a l ss i n c ee v e nm o d e r a t es o d i u m
channel densities (30/μm
2 in a 1.0 μmd i a m e t e ra x o n )
can produce spontaneous firing as a result of channel
noise or spontaneous channel opening in the context of
a high input resistance, low capacitance per unit length,
and shorter length constant [29-31].
While the presence of sodium channels along axons is
not unexpected, the precise functional roles of each of the
four sodium channel isoforms within intra-epidermal
nerve terminals remain to be determined. The sodium
channel isoforms that we have observed in intra-epidermal
nerve terminals display a spectrum of biophysical and
physiological properties which tune them so that they sup-
port sodium influx over a range of voltage and time
domains. NaV1.6, the major channel at nodes of Ranvier
[32], is also present along the trunks of central non-myeli-
nated axons [33] and peripheral C-fibers [23] and, as a
result of rapid recovery from inactivation [34], produces
sodium influx that contributes to high-frequency firing.
NaV1.7 displays slow closed-state inactivation [34,35] and
generates an inward sodium current in response to small
slow depolarizing inputs such as generator potentials in
the subthreshold range. NaV1.8 displays rapid recovery
from inactivation [36] and depolarized activation and inac-
tivation voltage-dependence [37] which permit it to gener-
ate a large inward sodium current during the rising phase
of the action potential [38,39] including high-frequency
firing in response to sustained depolarization [39]. NaV1.9
displays broad overlap between activation and inactivation
together with extremely slow inactivation [40], and can
generate a persistent sodium current at subthreshold
potentials so as to amplify and prolong depolarizing
inputs, decrease action potential threshold, and depolarize
resting potential [41,42]. Although the majority of NaV1.9
[40] and possibly other sodium channels may be inacti-
vated at the resting potential of sensory terminals [8],
expression and current density of NaV1.7 [43,44], NaV1.8
[45-47] and NaV1.9 [6,41] are known to be up-regulated
by pro-inflammatory molecules, so that these channels
may contribute to sensory axon sensitization under condi-
tions of inflammation.
Small caliber C- and Aδ-fibers that terminate as free
nerve endings in the epidermis each represent spatially
and molecularly heterogeneous populations, expressing
non-uniform combinations of ligand-mediated ionotro-
pic and metabotropic receptors, voltage-gated ion
channels, heat/cold receptors and neuropeptides (see e.
g. [1]). For instance, nerve endings expressing the G-
protein coupled receptor Mrgprd terminate in the stra-
tum granulosum [4], where they are suggested to play
an important role in noxious mechanical nociception
[48]. Conversely, the non-overlapping peptidergic,
TRPV1
+ nerve endings terminate in stratum spinosum
and appear to participate in noxious heat sensitivity
[4,48]. Most intra-cutaneous nerve terminals express
NaV1.7, NaV1.8 and NaV1.9, while NaV1.6 is detectable
in 70% of the nerve endings. It is not clear whether the
different subsets of free nerve endings exhibit different
patterns of sodium channel expression.
The expression of NCX2 along intra-epidermal nerve
terminals provides a molecular substrate for sodium-
calcium exchange in these fibers. NCX is known to be
present along the trunks of myelinated axons [16]
where, under normal (non-pathological) conditions,
sodium-calcium exchange is coupled to sodium influx,
and contributes to calcium extrusion following physiolo-
gical activity [17]. However, the presence of NCX2
together with sodium channels within epidermal noci-
ceptive terminals may also have pathophysiological
implications. Even a small ongoing sodium influx
m a yi n c r e a s ei n t r a c e l l u l a rs odium levels within small-
diameter axons, which have a large surface-volume
ratio, thereby imposing a substantial energetic load [49].
Persistent currents and ramp responses to small, slow
depolarizations are produced over multiple overlapping
voltage domains extending from the resting potential of
DRG neuron somata to nearly 0 mV by the sodium
channels present within these sensory terminals, NaV1.6
[50,51], NaV1.7 [35], NaV1.8 [52] and NaV1.9 [40]. Per-
sistent sodium influx via sodium channels has been
shown to drive injurious, calcium-importing reverse
sodium-calcium exchange in myelinated axons under
conditions of energy deprivation such as anoxia or
ischemia [53-55]. In addition, repetitive action potential
activity at physiological frequencies can also render
axons vulnerable to metabolic insults so that a combina-
tion of energy deprivation and electrical activity can lead
to axonal degeneration [56]. Expression of NCX2
together with sodium channels in intra-epidermal axon
terminals may thus make these fine-diameter nerve
fibers especially sensitive to injury when energetically
challenged.
Conclusions
I nt h i ss t u d yw ee x a m i n e dt h eexpression and distribu-
tion of isoforms of the sodium-calcium exchanger
(NCX) and voltage-gated sodium channels NaV1.6,
NaV1.7, NaV1.8 and NaV1.9 in intra-epidermal free
nerve endings, which include nociceptors. Our data
demonstrate that the sodium-calcium exchanger isoform
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endings. We also demonstrate that most intra-epidermal
nerve endings express sodium channels NaV1.6, NaV1.7,
NaV1.8 and NaV1.9. Similar patterns of sodium channel
and NCX2 expression were demonstrated along the
neurites and at the neuritic tips of cultured DRG neu-
rons. The expression of NCX2 and sodium channels
may have implications for the physiology and pathophy-
siology of fine-diameter intra-epidermal nerve endings.
Methods
Animals
Male Sprague-Dawley rats (Harlan, Indianapolis, IN)
were housed under a 12 hr light/dark cycle in a patho-
gen-free area with ad libitum access to water and food.
Animal use followed guidelines established by NIH and
a protocol approved by the VA Connecticut Healthcare
System Institutional Animal Care and Use Committee.
Antibodies
Antibodies against sodium channel isoforms NaV1.1
(rabbit; Alomone Laboratories, Jerusalem, Israel), NaV1.1
( m o u s e ;A n t i b o d i e s ,I n c . ,D a v i s ,C A ) ,N a V1.6 (rabbit;
S i g m a - A l d r i c hI n c . ,S t .L o u i s ,M O ) ,N a V1.7 (rabbit;
Y083, [57]), NaV1.8 (rabbit; Alomone), NaV1.8 (mouse;
Antibodies Inc) and NaV1.9 (rabbit; #6464, [58]) were
used in this study. Na
+/Ca
2+ exchanger (NCX) isoforms
were detected using antibodies against, NCX1 (rabbit;
Santa Cruz Biotechnology Inc., Santa Cruz, CA), NCX2
(goat; Santa Cruz Biotechnology Inc.) and NCX3 (rabbit;
Lifespan Biosciences, Seattle, WA). Anti-Protein Gene
Product (PGP) 9.5 (mouse; EnCor Biotechnology Inc.,
Gainesville, FL), anti-Peripherin (mouse; Abcam, Cam-
bridge, MA) and anti-Peripherin (chicken; Aves Labs
Inc., Tigard, OR) were used as neuronal markers and
anti-GFP (rabbit; Invitrogen, Carlsbad, CA) to enhance
EGFP signal of transfected neurons.
Immunohistochemistry of intra-epidermal terminals
Adult (225-250 g) male rats were deeply anesthetized
with ketamine/xylazine (80/8 mg/kg b.w., i.p.) and trans-
cardially perfused with phosphate buffered saline (PBS)
followed by a 4% paraformaldehyde solution in 0.14 M
Sorensen’s phosphate buffer. Dorsal root ganglia and the
glabrous skin from the plantar surface of the hindpaws
were dissected and cryoprotected with 30% sucrose in
0.14 M phosphate overnight at 4°C, cryostat sectioned
(12 μm) and mounted on glass slides (Fischer Super-
Frost Plus) prior to staining. Immunocytochemistry pro-
cedures were performed as previously described [58].
Briefly, sections were blocked with PBS containing 5%
fish skin gelatin (Sigma), 3% normal donkey serum, 0.3%
Triton X-100, and 0.02% sodium azide for 1 hour at
room temperature. Subsequently, slides were incubated
individually or in combination with primary antibodies
(rabbit anti-NaV1.1, 1:100, rabbit anti-NaV1.6, 1:100,
rabbit anti-NaV1.7, 1:200, rabbit anti-NaV1.8, 1:200,
mouse anti-NaV1.8, 1:100, rabbit anti-NaV1.9, 1:500, rab-
bit anti-NCX1, 1:100, goat anti-NCX2, 1:100, rabbit
anti-NCX3, 1:100, and mouse anti-PGP 9.5, 1:2000,
diluted in blocking solution, for 2 days at 4°C. Following
extensive PBS washes, tissue was incubated in appropri-
ate secondary antibody(ies): donkey anti-mouse IgG-488
(1:1000, Invitrogen), donkey anti-mouse IgG-549 (1:750,
Jackson ImmunoResearch, West Grove, PA), donkey
anti-rabbit IgG-488, donkey anti-rabbit IgG-Cy3, donkey
anti-goat 488 or donkey anti-goat 549 (all 1:500, Jackson
ImmunoResearch) diluted in blocking solution for 1 day
at 4°C. After extensive washes, slides were coverslipped
with Aqua-poly-mount (Polysciences, Warrington, PA).
Control experiments performed without primary antibo-
dies did not show labeling above background levels
(data not shown).
Immunocytochemistry of DRG neurons in vitro
Cultured wildtype- or transfected rat DRG neurons were
fixed with 4% paraformaldehyde for 10 minutes, washed,
incubated with primary antibodies (rabbit NaV1.6, 1:100,
rabbit NaV1.7, 1:200, mouse NaV1.8, 1:100, rabbit
NaV1.9, 1:500, rabbit NCX1, 1:100, goat NCX2, 1:100,
rabbit NCX3, 1:100, rabbit GFP, 1:1000, mouse periph-
erin, 1:1000, and chicken peripherin, 1:100, for 2 hours
at room temperature, washed, incubated in donkey anti-
mouse IgG-549 (1:750, Jackson ImmunoResearch), don-
key anti-rabbit IgG-488, donkey anti-rabbit IgG-Cy3,
donkey anti-goat IgG-488 or donkey anti-chicken 488
(all 1:500, Jackson ImmunoResearch) for 1 hour at room
temperature. Following washing, neurons were mounted
on glass slides with Aqua-poly-mount (Polysciences).
Image acquisition and analysis
Tissue and coverslips were examined with a Nikon C1si
confocal microscope (Nikon USA, Melville, NY). Using
EZ-C1 software (Nikon USA), digital images were
accrued from a single z plane, or as a series of digital
images in the x-y plane incremented by 0.4-0.7 μmi n
the z plane. For assessment of the percentage of free
nerve endings expressing NCX2 or sodium channel iso-
forms, PGP 9.5-positive free nerve endings were identi-
fied (blindly with respect to the sodium channel/NCX2
immunosignal) with the green channel and then the
sodium channel or NCX2 labeling was visualized in the
red channel. The percentages of nerve terminals exhibit-
ing immunolabeling clearly above background were
determined. Fields were chosen in which immunosignal
from keratinocytes (which are known to express varying
levels of a number of sodium channel isoforms [24])
was minimal, so as not to obscure the labeling of the
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Page 10 of 13much thinner axons and terminals. Images were pro-
cessed and composed in Adobe Photoshop (Adobe Sys-
tems, Mountain View, CA).
DRG cultures and transfection
Dorsal root ganglion neurons from (4-8 week old) rats
were isolated and cultured as previously described [44],
with neuronal enrichment as described by Shortland et al
[59]. As an alternative method for visualization of NaV1.6
and NaV1.7, transfection of DRG neurons with pcDNA3-
NaV1.6R-EGFP or pcDNA3-NaV1.7R -EGFP-vectors was
performed as previously described [21]. Briefly, 3 μgo f
channel plasmid was electroporated into the freshly-
isolated DRG neurons using Rat Neuron Nucleofector
Solution (Lonza, Walkerville, MD). Following the plating
of transfected DRG neurons onto laminin-coated glass
coverslips, cultures were maintained in DMEM/F12 sup-
plemented with 10% fetal calf serum, penicillin/strepto-
mycin, and nerve growth factor and glial cell-derived
neurotrophic factor (50 ng/ml each) at 37°C and 5% CO2.
Images of transfected neurons were obtained 2-4 days
following transfection.
Plasmids
NaV1.6-EGFP
The plasmid pcDNA3-NaV1.6R, which encodes full-
length mouse NaV1.6 rendered resistant to tetrodotoxin
(TTX-R) by the Y371 S substitution [34], was modified
by an in-frame fusion of enhanced green fluorescent
protein (EGFP) to the C-terminus. By mutagenesis using
QuikChange II XL mutagenesis kit (Stratagene, La Jolla,
CA), a unique KpnI restriction site, which removed the
translation termination codon (TAG), and a unique
XbaI restriction site 3’ of the KpnI site were introduced.
The coding sequence for EGFP was then cut from
pEGFP-N3 (BD Biosciences, San Jose, CA) with the
same enzymes, and was cloned into the KpnI and XbaI
sites of pcDNA3-NaV1.6 R. This resulted in the fusion of
EGFP to the C-terminus of the NaV1.6 open reading
frame with a linker sequence of 10 amino acids. Finally,
the length of this linker was extended to 19 amino acids
by insertion of oligonucleotides into the KpnI site,
which improved the green fluorescence intensity of the
fusion protein (data not shown). This final plasmid con-
struct is referred to as NaV1.6-EGFP. ND7/23 cells were
transiently transfected with the NaV1.6-EGFP vector and
fast-activating and fast-inactivating TTX-R Na
+ currents
comparable to NaV1.6R currents were recorded from
ND7/23 cells exhibiting green fluorescence (unpublished
data).
NaV1.7-EGFP
The pcDNA3-NaV1.7R-EGFP construct was generated by
inserting an EGFP-coding sequence into pcDNA3-
NaV1.7R using QuikChange II XL mutagenesis kit
(Stratagene) and Quick ligation kit (NEB, Ipswich, MA).
Briefly, the translation termination codon (TAG) of
NaV1.7R was removed and two unique restriction sites
(one ApaI and one NotI site) were introduced down-
stream the coding region of NaV1.7R using QuikChange
II XL mutagenesis kit to generate pcDNA3-NaV1.7R-
ApaI-NotI vector. The EGFP coding sequence was then
amplified from pEGFP-N3 vector (BD Biosciences) with a
forward primer containing an ApaI site and a reverse pri-
mer containing a NotI site. The EGFP fragments were
digested with ApaI and NotI restriction endonucleases
a n dc l o n e di n t op c D N A 3 - N a V1.7R-ApaI-NotI using T4
DNA ligase, generating pcDNA3-NaV1.7R-EGFP vector.
T h el i n k e rb e t w e e nt h eC - t e r m i n u so fN a V1.7R and the
N-terminus of EGFP is 16 amino acids in pcDNA3-
NaV1.7R-EGFP vector. HEK293 cells were transiently
transfected with pcDNA3-NaV1.7R-EGFP vector. Fast-
activating and fast-inactivating Na
+ currents comparable
to NaV1.7R currents were recorded from HEK293 cells
exhibiting green fluorescence (unpublished data).
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